Citigroup Inc. vs Canopy Growth Corp — how do they compare? Citigroup Inc. trades at $135.73 (market cap $226.82B), while Canopy Growth Corp trades at $1 (market cap $399.40M). The key difference: Citigroup Inc. is far larger — about 567.9× Canopy Growth Corp's market cap, and Citigroup Inc. pays a 1.98% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| C | CGC | |
|---|---|---|
Market Cap | $226.82B | $399.40M |
Sector | Financials | Health |
52-Week High | $145.67 | $1.92 |
52-Week Low | $92.59 | $0.86 |
Dividend Yield | 1.98% | — |
Enterprise Value | — | $356.90M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CGC trades at $0.9701, up 4.07% in 24 hours, with a neutral technical signal and mixed analyst ratings (9 buy, 11 hold, 7 sell). The company reported Q1 2027 revenue growth of 13% year-over-year but continues to post net losses, with a negative net income margin of -92.38% in 2026. Cash flow trends show improving operational efficiency, though negative operating cash flow persists. Recent news highlights progress on profitability measures and anticipation of U.S. cannabis rescheduling decisions.
The outlook remains cautious due to persistent unprofitability and regulatory uncertainties, but cost-cutting and revenue growth offer potential upside. Key risks include high debt, competitive pressures, and delayed federal cannabis reforms. Analysts are divided, reflecting the stock's high-risk, high-reward profile amid ongoing turnaround efforts.
Trailing returns across standard periods
Latest headlines on both assets
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →